Results 201 to 210 of about 105,856 (292)

Medicare Part D and Hospital Admissions due to Antimicrobial Resistance

open access: yesHealth Economics, Volume 35, Issue 5, Page 759-777, May 2026.
ABSTRACT Antimicrobial resistance (AMR) has been increasing rapidly in the United States despite government efforts to contain its spread. Both under‐utilization and overuse of prescribed antimicrobials contribute to rising resistance. The introduction of Medicare Part D in 2006 expanded prescription drug coverage for the elderly, including coverage ...
Ricardo B. Ang III
wiley   +1 more source

Disparities in Proton Radiation Utilization for HPV‐Associated Oropharyngeal Cancer Following TORS

open access: yesHead &Neck, Volume 48, Issue 5, Page 1218-1224, May 2026.
ABSTRACT Introduction Racial, socioeconomic, and geographic disparities in receipt of proton radiation have been reported. Whether disparities exist for oropharyngeal squamous cell carcinoma (OPSCC) is not well studied. Methods Patients with HPV‐associated OPSCC treated with transoral robotic surgery (TORS) and adjuvant radiation from 2016 to 2023 were
Jane Y. Tong   +4 more
wiley   +1 more source

Epidemiology of Traumatic Brain Injury in Medicare Beneficiaries over the Last Decade: A Retrospective Observational Study

open access: yesHealth Science Reports, Volume 9, Issue 5, May 2026.
ABSTRACT Background and Aims Older adults have higher rates of traumatic brain injuries (TBI) than other age groups, accounting for most TBI‐related hospitalizations and mortality. However, there is no up‐to‐date data on annual trends and regional differences in older Medicare beneficiaries.
Lidia MVR Moura   +6 more
wiley   +1 more source

Disease Burden and Pharmacological Treatment Patterns in Children and Adults With Phenylketonuria: A Real‐World Matched Cohort Study

open access: yesJournal of Inherited Metabolic Disease, Volume 49, Issue 3, May 2026.
ABSTRACT Phenylketonuria (PKU) is caused by defective catabolism of phenylalanine (Phe), resulting in Phe accumulation and subsequent neurocognitive impairment. This retrospective study used a large United States claims database linked to laboratory records (6/2018–05/2023) to compare comorbidities, healthcare resource utilization, and healthcare costs
Nicola Longo   +9 more
wiley   +1 more source

The Comparative Advantage of Medicare Advantage

open access: yes, 2018
Joseph Newhouse   +5 more
openaire   +1 more source

Hepatitis C Virus and Type 2 Diabetes: Mechanisms, Clinical Impact, and Post‐DAA Management

open access: yesJournal of Medical Virology, Volume 98, Issue 5, May 2026.
ABSTRACT Hepatitis C virus (HCV) infection remains a major global health burden despite advances in direct‐acting antiviral (DAA) therapies. Beyond hepatic complications such as cirrhosis and hepatocellular carcinoma (HCC), HCV has been strongly linked to metabolic disorders, particularly type 2 diabetes mellitus (T2DM).
Shen‐Shong Chang   +3 more
wiley   +1 more source

Real‐world predictors of progression to type 2 diabetes among adults with prediabetes

open access: yesDiabetes, Obesity and Metabolism, Volume 28, Issue 5, Page 3985-3996, May 2026.
Abstract Aims Assess predictors of progression to type 2 diabetes (T2D) among patients with prediabetes. Materials and methods This case–control study assessed adults with prediabetes using US claims and EMR‐linked data from January 1, 2016, through January 31, 2024.
Tyler Dunn   +7 more
wiley   +1 more source

Home - About - Disclaimer - Privacy